High Prevalence of Metabolic Dysfunction–Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology Clinics

Metabolic dysfunction-associated steatohepatitis (MASH) is a leading cause of cirrhosis. NIS2+ is a recently approved serum-based test combining two biomarkers (miR-34a-5p and YKL-40) to identify at-risk MASH (i.e., MASH and significant fibrosis).